In the present review, we focus on recent developments addressing the importance of STAT3 in cardiac hypertrophy, myocardial infarction (MI), heart failure, and peripartum cardiomyopathy, with particular focus on the contribution of immunity and inflammation. Here, STAT3 is linked to myocardial infarction.